Cargando…
Restoration of MHC-I on Tumor Cells by Fhit Transfection Promotes Immune Rejection and Acts as an Individualized Immunotherapeutic Vaccine
The capacity of cytotoxic-T lymphocytes to recognize and destroy tumor cells depends on the surface expression by tumor cells of MHC class I molecules loaded with tumor antigen peptides. Loss of MHC-I expression is the most frequent mechanism by which tumor cells evade the immune response. The resto...
Autores principales: | Pulido, María, Chamorro, Virginia, Romero, Irene, Algarra, Ignacio, S-Montalvo, Alba, Collado, Antonia, Garrido, Federico, Garcia-Lora, Angel M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352176/ https://www.ncbi.nlm.nih.gov/pubmed/32545680 http://dx.doi.org/10.3390/cancers12061563 |
Ejemplares similares
-
MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy
por: Romero, Irene, et al.
Publicado: (2018) -
Restored expression of Fhit protein in Fhit-minus breast cancer cells
por: Campiglio, M, et al.
Publicado: (2001) -
A new extract of the plant calendula officinalis produces a dual in vitro effect: cytotoxic anti-tumor activity and lymphocyte activation
por: Jiménez-Medina, Eva, et al.
Publicado: (2006) -
The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis
por: Jiménez-Medina, Eva, et al.
Publicado: (2008) -
FHIT gene and cancer.
Publicado: (1996)